CORC

在结果中检索

CORC

浏览/检索结果: 共60条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文
THORACIC CANCER, 2021, 页码: 9
作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
收藏  |  浏览/下载：19/0  |  提交时间：2021/05/24
PI3K alpha inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8(+)T cells and promoting fatty acid metabolism 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9, 期号: 8, 页码: 16
作者:  Sun, Pu;  Zhang, Xi;  Wang, Rong-Jing;  Ma, Qing-Yang;  Xu, Lan
收藏  |  浏览/下载：42/0  |  提交时间：2021/11/04
Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1) 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 195, 页码: 13
作者:  Zhang, Shiyan;  Huang, Chaoying;  Lyu, Xilin;  Wang, Peipei;  Zang, Yi
收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:  Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei
收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26
Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo [d] azepin-7-yl)amino)pyrazine core 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 卷号: 29, 期号: 6, 页码: 836-838
作者:  Wang, Yueliang;  Xing, Li;  Ji, Yinchun;  Ye, Jiqing;  Dai, Yang
收藏  |  浏览/下载：15/0  |  提交时间：2020/07/01
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19
Preclinical pharmacodynamics evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma. 期刊论文
Cancer science, 2019
作者:  Yang Wei;  Meng Lingwei;  Chen Kai;  Tian Chenyu;  Peng Bing
收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology 期刊论文
PLOS COMPUTATIONAL BIOLOGY, 2019, 卷号: 15, 期号: 6
作者:  Lim, Hansaim;  He, Di;  Qiu, Yue;  Krawczuk, Patrycja;  Sun, Xiaoru
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/11
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace